In this issue:
Metabolic syndrome and psoriasis: frequent comorbidity
Adalimumab for psoriasis of the hands and feet
betaPV infection in psoriasis and atopic dermatitis
Methotrexate vs fumarates in moderate to severe psoriasis
Cardiovascular safety of ustekinumab
Comparison of drug survival rates for
TNF-α inhibitors
Infliximab effective in nail psoriasis
Safety of anti-TNF-α in concurrent psoriasis and HBV
TNF-α inhibitor-related HBV or HCV reactivation: low risk
Systemic treatments in nail psoriasis
Please login below to download this issue (PDF)